Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Don??t Alp??r
Affiliation
Semmelweis University
ORCID
Career Start Year
2006
Papers
47
H Index
13
Expertise
CM4AI Collaborator
Nathan Sheffield (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37987115
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
J Pathol Clin Res
2024
37239898
Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort.
Int J Mol Sci
2023
37259686
Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.
J Intern Med
2023
37088137
Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid Leukemia.
J Mol Diagn
2023
36982875
Landscape of <i>BCL2</i> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.
Int J Mol Sci
2023
36980598
The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries.
Cancers (Basel)
2023
37340093
PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.
Br J Cancer
2023
34332791
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
Pathology
2022
34080325
The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
Cancer Med
2021
33671014
NGS-Based Application for Routine Non-Invasive Pre-Implantation Genetic Assessment in IVF.
Int J Mol Sci
2021
33588158
Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases.
ESMO Open
2021
34830811
Single-Cell Sequencing: Biological Insight and Potential Clinical Implications in Pediatric Leukemia.
Cancers (Basel)
2021
34019713
Screening and monitoring of the BTK<sup>C481S</sup> mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy.
Br J Haematol
2021
31180577
Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib.
Int J Cancer
2020
31996669
Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL.
Nat Commun
2020
31857684
Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia.
Mod Pathol
2020
31886867
Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.
J Neuropathol Exp Neurol
2020
32824053
Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis.
Cancers (Basel)
2020
32668764
Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma.
Genes (Basel)
2020
30262564
Spatial clonal evolution leading to ibrutinib resistance and disease progression in chronic lymphocytic leukemia.
Haematologica
2019
31748746
Longitudinal molecular trajectories of diffuse glioma in adults.
Nature
2019
31433233
[Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].
Orv Hetil
2019
29306106
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms.
Leuk Res
2018
30150718
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.
Nat Med
2018
30096382
High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma.
J Mol Diagn
2018
29631426
[Multiplex ligation-dependent probe amplification in oncohematological diagnostics and research].
Orv Hetil
2018
27870946
Conserved hierarchical gain of chromosome 4 is an independent prognostic factor in high hyperdiploid pediatric acute lymphoblastic leukemia.
Leuk Res
2017
28099430
Pooled CRISPR screening with single-cell transcriptome readout.
Nat Methods
2017
27275635
[Introduction to the molecular diagnostic methods of oncohematology].
Magy Onkol
2016
27275638
[The genetic landscape of chronic lymphocytic leukemia].
Magy Onkol
2016
24897505
Evolutionary trajectories of hyperdiploid ALL in monozygotic twins.
Leukemia
2015
25388957
Clonal origins of ETV6-RUNX1⺠acute lymphoblastic leukemia: studies in monozygotic twins.
Leukemia
2015
25174722
Sequential and hierarchical chromosomal changes and chromosome instability are distinct features of high hyperdiploid pediatric acute lymphoblastic leukemia.
Pediatr Blood Cancer
2014
22528566
Six cases of rare gene amplifications and multiple copy of fusion gene in childhood acute lymphoblastic leukemia.
Pathol Oncol Res
2013
23720363
Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
Genes Chromosomes Cancer
2013
22615107
Automated signal pattern evaluation of a bladder cancer specific multiprobe-fish assay applying a user-trainable workstation.
Microsc Res Tech
2012
22939399
MLPA is a powerful tool for detecting lymphoblastic transformation in chronic myeloid leukemia and revealing the clonal origin of relapse in pediatric acute lymphoblastic leukemia.
Cancer Genet
2012
22696411
State-of-the-art FISHing: automated analysis of cytogenetic aberrations in interphase nuclei.
Cytometry A
2012
21465665
Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria.
Cytometry A
2011
21547032
Recurrent disease or donor cell leukemia?: Brain teaser after allogeneic bone marrow transplantation.
Chimerism
2011
21377730
Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
Leuk Res
2011
19813247
Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
Pediatr Blood Cancer
2010
20979181
Sex chromosome changes after sex-mismatched allogeneic bone marrow transplantation can mislead the chimerism analysis.
Pediatr Blood Cancer
2010
18393324
Automated FISH analysis using dual-fusion and break-apart probes on paraffin-embedded tissue sections.
Cytometry A
2008
18228559
Increased efficiency of detecting genetically aberrant cells by UroVysion test on voided urine specimens using automated immunophenotypical preselection of uroepithelial cells.
Cytometry A
2008
17284366
Automated detection of residual leukemic cells by consecutive immunolabeling for CD10 and fluorescence in situ hybridization for ETV6/RUNX1 rearrangement in childhood acute lymphoblastic leukemia.
Cancer Genet Cytogenet
2007
16646048
Automated fluorescent in situ hybridization (FISH) analysis of t(9;22)(q34;q11) in interphase nuclei.
Cytometry A
2006
1 - 47 of 47
Column Actions
Search
Recommended Authors
Beth A Pitel
Mayo Clinic
Career Start Year
2017
Number of shared co-authors
0
David Shabsovich
university of california los angeles Medical Center
Career Start Year
2013
Number of shared co-authors
0
Panagiotis Baliakas
Uppsala University
Career Start Year
2012
Number of shared co-authors
0
Xinjie Xu
Mayo Clinic
Career Start Year
2011
Number of shared co-authors
0
David Wu
University of Washington
Career Start Year
2010
Number of shared co-authors
0
Christopher A Miller
Washington University School of Medicine
Career Start Year
2009
Number of shared co-authors
1
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year
2007
Number of shared co-authors
0
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
1
Manuela Krumbholz
University Hospital Erlangen
Career Start Year
2006
Number of shared co-authors
4
Emmanuelle Clappier
Saint-Louis Hospital
Career Start Year
2005
Number of shared co-authors
1
Alexander Kohlmann
Oncology R&D
Career Start Year
2002
Number of shared co-authors
1
Gudrun G??hring
Hannover Medical School
Career Start Year
2002
Number of shared co-authors
1
Thomas Ernst
Universitatsklinikum Jena
Career Start Year
2002
Number of shared co-authors
0
Marilyn M Li
Children's Hospital of Philadelphia
Career Start Year
2000
Number of shared co-authors
1
Guang Fan
Oregon Health and Science University
Career Start Year
2000
Number of shared co-authors
0
Markus Metzler
University Hospital Erlangen
Career Start Year
1998
Number of shared co-authors
7
Gordana Raca
Children's Hospital Los Angeles
Career Start Year
1997
Number of shared co-authors
0
Charles G Mullighan
St Jude Children's Research Hospital
Career Start Year
1996
Number of shared co-authors
1
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year
1996
Number of shared co-authors
4
Michael Baudis
University of Zurich
Career Start Year
1995
Number of shared co-authors
3
Anthony V Moorman
Translational and Clinical Research Institute, Newcastle University
Career Start Year
1994
Number of shared co-authors
0
Doris Steinemann
Hannover Medical School
Career Start Year
1994
Number of shared co-authors
2
Jean Soulier
University of Paris
Career Start Year
1993
Number of shared co-authors
1
Seishi Ogawa
Kyoto University
Career Start Year
1993
Number of shared co-authors
6
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year
1992
Number of shared co-authors
3
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year
1992
Number of shared co-authors
0
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year
1989
Number of shared co-authors
1
Krzysztof Mr??zek
The Ohio State Comprehensive Cancer Center
Career Start Year
1988
Number of shared co-authors
0
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
0
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
1983
Number of shared co-authors
7
row(s) 1 - 30 of 30
Collaborators
Karoly Szuhai
Leiden University Medical Center
Co-authored papers
8
Christoph Bock
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers
5
Georg Widhalm
Medical University of Vienna
Co-authored papers
3
Johanna Klughammer
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers
2
Karin Dieckmann
Medical University of Vienna
Co-authored papers
2
Nikolaus Fortelny
University of Salzburg
Co-authored papers
2
Paul Datlinger
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers
2
Matthias Preusser
Medical University of Vienna
Co-authored papers
2
Amelie Nemc
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers
2
Adelheid Woehrer
Medical University of Vienna
Co-authored papers
2
Christian Schmidl
Leibniz Institute for Immunotherapy
Co-authored papers
2
Andr?? F Rendeiro
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers
2
Johannes A Hainfellner
Medical University of Vienna
Co-authored papers
2
Waltraud Kleindienst
Paracelsus Medical University Salzburg
Co-authored papers
1
Priscilla K Brastianos
Co-authored papers
1
Pim J French
Erasmus MC Cancer Institute
Co-authored papers
1
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers
1
G??nther Stockhammer
Medical University of Innsbruck
Co-authored papers
1
Thomas Str??bel
Indiana University School of Medicine
Co-authored papers
1
Bernhard Baumann
Medical University of Vienna, Center for Medical Physics and Biomedical Engineering
Co-authored papers
1
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers
1
Kenneth Aldape
National Cancer Institute
Co-authored papers
1
Tathiane M Malta
School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo
Co-authored papers
1
Matthias Farlik
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers
1
Joseph F Costello
University of California san francisco
Co-authored papers
1
Astrid E Grams
Medical University of Innsbruck
Co-authored papers
1
Michael Schuster
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers
1
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers
1
Roel G W Verhaak
Yale School of Medicine
Co-authored papers
1
Pratiti Bandopadhayay
Co-authored papers
1
1 - 30